Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus for Refractory Pure Red Cell Aplasia
NCT03540472Phase 4Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jun 2018
- Primary completion
- Dec 2018
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in pure red cell aplasia (PRCA), sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
tacrolimus
03
Conditions
pure red cell aplasia (PRCA)
Beyond the preview
Go deeper on NCT03540472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03540472.